These results are in line with those obtained in a study with 200 Caucasian patients (Australia) diagnosed with rheumatoid arthritis and treated with MTX at low doses, where no association was found between the ABCC1 rs35592 SNP and the presence of toxicity (p > 0.05) [87]. The gene discussed is ABCC1; the disease is rheumatoid arthritis.